John O'Quigley, Professor
Completed supervision of doctoral and post-doctoral students;
Robert Blizzard 1990;
Bessel function and Edgeworth approximations for permutation distributions.
Current position: Professor of Biostatistics, University College London.
Fabienne Pessione 1992 ;
Inversion of regression effect in survival studies: applications in bone marrow transplantation.
Current position: Epidemiologist, Hôpital Beaujon, Clichy, France.
Sylvie Chevret 1994 ;
Impact of model choice in a Phase I clinical trial.
Current position: Professor of Biostatistics and Medical Informatics, Hôpital Saint Louis, Paris, France.
Larry Shen 1994 ;
Asymptotic theory of stochastic approximation methods.
Current position; Chief of Biostatistics. Amylin Pharmaceuticals, San Diego, California.
Philippe Flandre 1995;
Surrogate endpoints in survival studies; application to clinical trials in AIDS.
Current position: Senior Research Scientist, AIDS Clinical Trials Group, Villejuif, France.
Ethan Reiner 1996;
Stopping rules for stochastically curtailed clinical trials.
Current position: Manager, Axa Investments, Paris, France
Ronghui Xu 1997;
Inference for the proportional hazards model.
Current position: Full Professor, Dept. of Mathematics, University of California at San Diego.
Reena Deutsch 1997;
Incubation period of the HIV virus.
Current position: Professor, Cancer Center, University of California at San Diego.
Cécile Parent 1998;
Change point models in survival analysis; application to breast cancer studies.
Current position: Unknown.
Katherine Gower 1999;
Models for carcinogenesis.
Current position: Statistician, Fred Hutchinson Cancer Research Center, Seattle.
Laurent Vabre 2000 ;
Incorporating PK/PD information into Phase I dose finding designs.
Current position: Epidemiologist/Practitioner RATP, Paris, France.
Xavier Paoletti 2002;
Optimality in Phase I and Phase II dose finding studies.
Current position: Associate Director of Biostatistics. Institut Curie, Paris, France.
Sarah Zohar 2005;
Efficiency of dose finding studies in cancer based on combining toxicity and treatment efficacy information.
Current position: Inserm Researcher, Centre d'Investigation Clinique (equivalent to CRC), Hôpital Saint Louis, Paris.
Nolan Wages 2010;
Dose finding designs for drug combinations.
Current position: Assistant Professor, Division of Biostatistics, University of Virginia.
Jianfen Shu 2012;
Heterogeneity models in dose finding studies.
Current position: Senior Statistician, PharmaNet/i3 International. California. U.S.A.
Cécile Chauvel 2014
Influence of model assumptions on prediction in survival models.
Current position: Senior Statistician, AXA, Grenoble.
Matthieu Clertant 2015
Inference for hierarchical statistical models.
Current position: Assistant Professor, Lancaster University, U.K.
Roxane Duroux 2016
Robustness of dose-finding algorithms in non-standard settings.
Current position: Professor Education Nationale, France.
David Guédé (Ph.d thesis)
Bayesian dose finding trials in healthy volunteers.
Christophe Peczynski (Ph.d thesis)
Clinical trials using smart data
Current position: Statistician, AdScientiam, Paris.